BeiGene, Ltd. Files 8-K on Operations and Financials

Ticker: BEIGF · Form: 8-K · Filed: Aug 29, 2024 · CIK: 1651308

Beigene, LTD. 8-K Filing Summary
FieldDetail
CompanyBeigene, LTD. (BEIGF)
Form Type8-K
Filed DateAug 29, 2024
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, operations

Related Tickers: BGNE

TL;DR

BeiGene dropped an 8-K update on financials and operations.

AI Summary

On August 29, 2024, BeiGene, Ltd. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.

Why It Matters

This 8-K filing indicates BeiGene, Ltd. is providing an update on its financial performance and operational status to the SEC.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of operational and financial information, not indicating any immediate adverse events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by BeiGene, Ltd.?

The primary purpose of this 8-K filing is to report on BeiGene, Ltd.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.

On what date was this 8-K report filed?

This 8-K report was filed on August 29, 2024.

What is BeiGene, Ltd.'s principal executive office address?

BeiGene, Ltd.'s principal executive offices are located at c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, Grand Cayman KY1-1108, Cayman Islands.

What is BeiGene, Ltd.'s telephone number?

BeiGene, Ltd.'s telephone number is +1 (345) 949-4123.

Under which section of the Securities Exchange Act of 1934 is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 900 words · 4 min read · ~3 pages · Grade level 10.8 · Accepted 2024-08-29 07:29:23

Key Financial Figures

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On August 29, 2024, BeiGene, Ltd. (the "Company") filed its 2024 Interim Report for the six months ended June 30, 2024 (the "STAR Interim Report") with the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange, which was prepared in accordance with the listing rules of the STAR Market and the applicable securities laws and regulations of the Peoples' Republic of China (the "PRC" and the "PRC Securities Laws"). As required by the PRC Securities Laws, the STAR Interim Report contains additional financial information of the Company for the six months ended June 30, 2024 (the "Reporting Period"), prepared in accordance with the China Accounting Standards for Business Enterprises – Basic Standard ("CAS") and other applicable PRC accounting rules, guidance and interpretations (together with CAS, "PRC GAAP"). As required by the PRC Securities Laws, the STAR Interim Report also contains financial information of the Company for the Reporting Period prepared in accordance with PRC GAAP. PRC GAAP are different from accounting principles generally accepted in the United States ("U.S. GAAP"). The financial information regarding the Company's research and development expenses allocated by key products and other research and development projects for the Reporting Period prepared in accordance with U.S. GAAP as well as a summary of the material differences between PRC GAAP and U.S. GAAP are attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The STAR Interim Report is available to the public in Chinese language only on the website maintained by the Shanghai Stock Exchange at www.sse.com.cn. The STAR Interim Report and the information contained on the Shanghai Stock Exchange's website are not part of this Current Report on Form 8-K and shall not be deemed filed or furnished by the Company with the U.S. Securities and Exchange Commi

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Financial Information, furnished herewith 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL Exhibit Index Exhibit No. Description 99.1 Financial Information, furnished herewith 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BEIGENE, LTD. Date: August 29, 2024 By: /s/ Chan Lee Name: Chan Lee Title: Senior Vice President, General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing